Compare MANU & SRPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MANU | SRPT |
|---|---|---|
| Founded | 1878 | 1980 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Services-Misc. Amusement & Recreation | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.7B | 2.3B |
| IPO Year | 2012 | 1997 |
| Metric | MANU | SRPT |
|---|---|---|
| Price | $16.35 | $23.16 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 29 |
| Target Price | N/A | ★ $26.23 |
| AVG Volume (30 Days) | 393.9K | ★ 2.8M |
| Earning Date | 02-18-2026 | 02-25-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $892,268,193.00 | ★ $2,413,715,000.00 |
| Revenue This Year | $0.01 | $13.72 |
| Revenue Next Year | $15.68 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | 2.48 | ★ 47.15 |
| 52 Week Low | $12.05 | $10.42 |
| 52 Week High | $19.65 | $129.84 |
| Indicator | MANU | SRPT |
|---|---|---|
| Relative Strength Index (RSI) | 61.07 | 61.68 |
| Support Level | $15.68 | $20.86 |
| Resistance Level | $16.17 | $22.00 |
| Average True Range (ATR) | 0.36 | 1.00 |
| MACD | 0.07 | 0.11 |
| Stochastic Oscillator | 88.21 | 78.57 |
Manchester United PLC operates as a professional football club with related activities, generating revenue prominently through commercial, broadcasting, and matchday segments. The commercial segment monetizes the various brands via sponsorships, retail, merchandising, apparel, and product licensing. Broadcasting revenue comes from television rights linked to football leagues and competitions, alongside content delivered through its dedicated TV channel all over the globe. Matchday income includes ticket sales, hospitality, merchandise, and services at its stadium. Manchester United is based in England. The company's operations and fan base extends to many countries, supporting a diversified revenue model based on brand engagement and football-related content.
Sarepta Therapeutics Inc is a biotechnology company focused on treating rare, infectious, and other diseases. It targets a broad range of diseases while focusing on the rapid development of its drug candidates. Sarepta's involves proprietary RNA-targeted technology platforms to be used for developing novel pharmaceutical products to treat a broad range of diseases and address key unmet medical needs. The company uses third-party contractors to manufacture its product candidates. Majority of company's product candidates are at an early stage of development.